Back to Journals » Lung Cancer: Targets and Therapy » Volume 2

Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer

Total article views   HTML views PDF downloads Totals
16,620 Dovepress* 13,774+ 5,077 18,851
PubMed Central* 2,846 271 3,117
Totals 16,620 5,348 21,968
*Since 14 October 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 0 5

View citations on PubMed Central and Google Scholar